share_log

华海药业(600521.SH):马来酸依那普利片获得药品注册证书

Zhejiang Huahai Pharmaceutical (600521.SH): Enalapril Maleate Tablets Obtained Pharmaceutical Registration Certificate.

Gelonghui Finance ·  Sep 18 05:09

Zhejiang Huahai Pharmaceutical (600521.SH) announced that the company and its subsidiary, Changxing Pharmaceutical Co., Ltd. (abbreviated as Changxing Pharmaceutical, securities code: 835269), recently received the "Drug Registration Certificate" issued by the National Medical Products Administration. The name of the pharmaceutical is "Perindopril Maleate Tablet". Perindopril Maleate Tablet is mainly used to treat primary hypertension at all stages, renal vascular hypertension, various stages of heart failure, prevent symptomatic heart failure, and prevent coronary artery ischemic events in patients with left ventricular dysfunction.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment